US Stock MarketDetailed Quotes

QNRX Quoin Pharmaceuticals

Watchlist
  • 0.3107
  • -0.0445-12.53%
Close Feb 28 16:00 ET
  • 0.3014
  • -0.0093-2.99%
Post 20:01 ET
6.40MMarket Cap-0.08P/E (TTM)

About Quoin Pharmaceuticals Company

Quoin Pharmaceuticals Ltd. engages in the development of therapeutic products for the treatment of rare and orphan diseases. Its product pipeline includes QRX003, QRX004, QRX007, and QRX008. The company was founded by Michael Myers and Denise Carter on March 5, 2018 and is headquartered in Ashburn, VA.

Company Profile

SymbolQNRX
Company NameQuoin Pharmaceuticals
Listing DateJul 29, 2016
Issue Price6.50
Founded1986
CEOMr. Michael Myers
MarketNASDAQ
Employees4
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
Address42127 Pleasant Forest Court
CityAshburn
ProvinceVirginia
CountryUnited States of America
Zip Code20148-7349
Phone1-703-980-4182
Websitehttp://www.quoinpharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Michael Myers
  • Chairman of the Board and Chief Executive Officer
  • 1.26M
  • Denise Carter
  • Director and Chief Operating Officer
  • 1.07M
  • Gordon Dunn
  • Chief Financial Officer and Principal Accounting Officer
  • 775.94K
  • Dr. Dennis H. Langer, J.D.,M.D.
  • Independent Director
  • 117.62K
  • Natalie Leong
  • Independent Director
  • 122.62K
  • Joseph P. Cooper
  • Independent Director
  • 112.62K
  • Anthony James Culverwell
  • Independent Director
  • 122.62K
  • Michael Sember
  • Independent Director
  • 107.62K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
LINTEX
920106
+30.00%
LINGOOD
833284
+29.98%
NTGEC
870436
+29.98%
4
CG MED EQUIP.
838810
+29.97%
5
Jiayu Holding
300117
+20.48%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Earnings Season Underway
Earnings season is here. What to know?
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More
TSLA earnings preview: Grab rewards by guessing the opening price!